Upregulation of PTPN11 phosphatases have been reported to mediate resistance to ALK-TKI in ALK+ anaplastic large cell lymphoma and in a variety of other cancers [42, 46]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.